Xilio Therapeutics (XLO) Interest Coverage Ratio (2020 - 2022)

Xilio Therapeutics has disclosed Interest Coverage Ratio across 3 years of filings, most recently posting 164.53 for Q1 2022.

• Interest Coverage Ratio for Q1 2022 came in at 164.53, down 46.4% year-over-year; the trailing twelve-month figure through Dec 2022 was 691.08 (down 435.96% YoY), and the FY2021 annual result was 99.26, down 19.34% from the prior year.
• Interest Coverage Ratio came in at 164.53 for Q1 2022 at Xilio Therapeutics, down from 134.87 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 55.04 in Q3 2021 to a low of 164.53 in Q1 2022.
• The 3-year median for Interest Coverage Ratio is 114.37 (2021), against an average of 109.63.
• Across the five-year window, Interest Coverage Ratio grew 26.23% in 2021 and sank 46.4% in 2022, its largest moves.
• Xilio Therapeutics' Interest Coverage Ratio stood at 116.36 in 2020, then dropped by 15.91% to 134.87 in 2021, then slipped by 21.99% to 164.53 in 2022.
• The last three Interest Coverage Ratio figures came in at 164.53 (Q1 2022), 134.87 (Q4 2021), and 55.04 (Q3 2021), per Business Quant data.